Suppression of Conditioned Fear by Administration of CRF Receptor Antagonist CP-154,526
The DOI matches its Crossref record.
Abstract
In order to examine the involvement of corticotropin-releasing hormone (CRF) receptor in the formation of anxiety, we investigated whether CRF receptor antagonist CP-154,526 suppressed conditioned fear stress. First, rats were individually subjected to 30 min of footshock. Twenty-four hours after footshock, the rats were again placed in the chamber and observed for 5 min without shock. CP-154,526 was administered 30 min before placing the rats in the chamber again. After that, CP-154,526 was once more administered 30 min before applying footshock. Administration of CP-154,526 30 min both before conditioned fear stress (placing the rats inside the cage but not applying footshock) and before actual footshock significantly reduced freezing behavior. These results show that CP-154,526 blocked both the acquisition and expression of conditioned fear, thus suggesting that the CRF receptor might be related to anxiety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is also evidence that CRF is involved in context conditioning.”
From Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety (2010) · cites this paper as Hikichi et al, 2000
Citations
Cites
Still being checked.
Cited by
Phasic vs Sustained Fear in Rats and Humans: Role of the Extended Amygdala in Fear vs Anxiety
Davis, M., Walker, D. L., Miles, L., & Grillon, C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.109 · Cited by 1,513
“Several authors have reported that freezing to contextual CSs was disrupted by CRF receptor antagonists (Deak et al, 1999; Hikichi et al, 2000; Kalin and Takahashi, 1990), and recent findings from Risbrough et al (2009), as well as from our own laboratory (Walker et al, 2009), Role of the extended…”
BackgroundCRF and CRF receptors: role in stress responsivity and other behaviors
Bale, T. L., & Vale, W. W. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121410 · Cited by 1,270
Hauger, R., Risbrough, V., Brauns, O., & Dautzenberg, F. (2006) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152706777950684 · Cited by 343
Walker, D. L., Miles, L. A., & Davis, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.022 · Cited by 331
Makino, S., Hashimoto, K., & Gold, P. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00791-8 · Cited by 260
The CRF Family of Neuropeptides and their Receptors - Mediators of the Central Stress Response
Dedic, N., Chen, A., & Deussing, J. M. (2018) · Current Molecular Pharmacology · doi:10.2174/1874467210666170302104053 · Cited by 182
The therapeutic potential of CRF1 antagonists for anxiety
Zorrilla, E. P., & Koob, G. F. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.7.799 · Cited by 176
Progress in corticotropin-releasing factor-1 antagonist development
Zorrilla, E. P., & Koob, G. F. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.011 · Cited by 167
Zorrilla, E. P., Valdez, G. R., Nozulak, J., Koob, G. F., & Markou, A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03189-x · Cited by 159
Pharmacotherapy of PTSD: premises, principles, and priorities.
Ravindran, L. N., & Stein, M. B. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.037 · Cited by 153
The Pharmacology of CP‐154,526, a Non‐Peptide Antagonist of the CRH1 Receptor: A Review
Seymour, P. A., Schmidt, A. W., & Schulz, D. W. (2003) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2003.tb00244.x · Cited by 112
Zorrilla, E. P., Heilig, M., de Wit, H., & Shaham, Y. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.12.017 · Cited by 108
Kehne, J. H., & Cain, C. K. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.011 · Cited by 105
Role of CRF receptor 1 in central CRF-induced stimulation of colonic propulsion in rats
Martínez, V., & Taché, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03277-7 · Cited by 101
Merali, Z., Khan, S., Michaud, D. S., Shippy, S. A., & Anisman, H. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03468.x · Cited by 82
Walker, D., Yang, Y., Ratti, E., Corsi, M., Trist, D., & Davis, M. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.210 · Cited by 69
“Effects of CRF receptor blockade on context-potentiated startle have not, to our knowledge, been previously reported, although effects on context CS-induced freezing have (e.g., Deak et al., 1999; Hikichi et al., 2000; Kalin and Takahashi, 1990).”
Background2-Aryloxy-4-alkylaminopyridines: Discovery of Novel Corticotropin-Releasing Factor 1 Antagonists
Chen, Y. L., Obach, R. S., Braselton, J. P., Corman, M. L., Forman, J. T., Freeman, J., Gallaschun, R. J., Mansbach, R. S., Schmidt, A. W., Sprouse, J. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070579c · Cited by 73
Swiergiel, A. H., ZHOU, Y., & Dunn, A. J. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.06.006 · Cited by 67
The Pharmacology of DMP696 and DMP904, Non-Peptidergic CRF1 Receptor Antagonists
Li, Y.-W., Fitzgerald, L. W., Wong, H. H., Lelas, S., Zhang, G., Lindner, M. D., Wallace, T. L., McElroy, J., Lodge, N. J., Gilligan, P. J., et al. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00034.x · Cited by 61
Characterization of anxiety and habituation profile following global ischemia in rats
Plamondon, H., & KHAN, S. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.02.001 · Cited by 61
Brielmaier, J., McDonald, C. G., & Smith, R. F. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2378-1 · Cited by 54
“This was an unexpected finding inlightofevidencethatCRF-R1antagonistsblockavarietyof behavioral stress responses in rodents, including shockinduced freezing (Bakshi et al. 2002 ;D eak et al.1999; Hikichi et al. 2000 ).”
BackgroundResultInfluentialLelas, S., Wong, H. H., Li, Y.-W., Heman, K. L., Ward, K. A., Zeller, K. L., Sieracki, K. K., Polino, J. L., Godonis, H. E., Ren, S. X., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.058784 · Cited by 57
Chen, Y. L., Braselton, J. P., Forman, J. T., Gallaschun, R. J., Mansbach, R. S., Schmidt, A. W., Seeger, T., Sprouse, J. S., Tingley, F. D., Winston, E., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070578k · Cited by 53
Differential involvement of amygdaloid CRH system(s) in the salience and valence of the stimuli
Merali, Z., Michaud, D. S., McIntosh, J. F., Kent, P., & Anisman, H. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.014 · Cited by 53
McElroy, J., Ward, K., Zeller, K. L., Jones, K., Gilligan, P. J., He, L., & Lelas, S. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1239-3 · Cited by 45
Yokoyama, F., Yamauchi, M., Oyama, M., Okuma, K., Onozawa, K., Nagayama, T., Shinei, R., Ishikawa, M., Sato, Y., & Kakui, N. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1528-1 · Cited by 38
Pickens, C. L., Adams‐Deutsch, T., Nair, S. G., Navarre, B. M., Heilig, M. A., & Shaham, Y. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.09.079 · Cited by 36
Cippitelli, A., Ayanwuyi, L. O., Barbier, E., Domi, E., Lerma-Cabrera, J. M., Carvajal, F., Scuppa, G., Li, H., Ubaldi, M., Heilig, M., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3743-7 · Cited by 31
CRHR1 Antagonists as Novel Treatment Strategies
Holsboer, F. (2001) · CNS Spectrums · doi:10.1017/s1092852900002133 · Cited by 30
Association and linkage analysis of candidate genes GRP, GRPR, CRHR1, and TACR1 in panic disorder
Hodges, L. M., Weissman, M. M., Haghighi, F. G., Costa, R., Bravo, O., Evgrafov, O. V., Knowles, J. A., Fyer, A. J., & Hamilton, S. P. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30773 · Cited by 32
Molecular Signaling and Translational Significance of the Corticotropin Releasing Factor System
Ronan, P. J., & Summers, C. H. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00006-5 · Cited by 28
Hogan, J. B., Hodges, D. B., Lelas, S., Gilligan, P. J., McElroy, J. F., & Lindner, M. D. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2028-y · Cited by 27
Chen, X., Li, S., & Kirouac, G. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.01.013 · Cited by 26
Isogawa, K., Bush, D. E. A., & LeDoux, J. E. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.08.021 · Cited by 28
Self-citationIsogawa, K., Akiyoshi, J., Tsutsumi, T., Kodama, K., Horinouti, Y., & Nagayama, H. (2003) · Journal of Psychopharmacology · doi:10.1177/0269881103174004 · Cited by 17
Self-citationCan CRF1 receptor antagonists become antidepressant and/or anxiolytic agents?
Overstreet, D. H., Knapp, D. J., & Breese, G. R. (2005) · Drug Development Research · doi:10.1002/ddr.20023 · Cited by 15
Lelas, S., Zeller, K. L., Ward, K. A., & McElroy, J. F. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1331-8 · Cited by 15
Merali, Z., Mountney, C., Kent, P., & Anisman, H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.056 · Cited by 10
Nalivaiko, E., & Blessing, W. W. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00818-7 · Cited by 9
CRF antagonists as novel treatment strategies for stress-related disorders
Steckler, T. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80065-3 · Cited by 7
Kumar, J. S. D., Majo, V. J., Prabhakaran, J., Simpson, N. R., Heertum, R. L. V., & Mann, J. J. (2003) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.738 · Cited by 7
Interactions between CRF and acetylcholine in the modulation of cognitive behaviour
Warnock, G., Prickaerts, J., & Steckler, T. (2006) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7772-4_3 · Cited by 7
Itomi, Y., Tanaka, T., Matsushita, K., Kawamura, T., Kojima, T., Aso, K., Matsumoto‐Okano, S., & Tsukimi, Y. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13795 · Cited by 4
Cholecystokinin knockout mice: peripheral and central phenotypes
Lo, C. C., Black, D. D., & Tso, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23720-1.00021-6 · Cited by 1
Romanowski, C. P. N. (2010) · Elektronische Hochschulschriften der LMU München (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.11851
Emerging Anxiolytics: Corticotropin‐Releasing Factor Receptor Antagonists
Grigoriadis, D. E., & Hoare, S. R. J. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn027
Chen, M., Meng, H., Li, X., Guan, K., Shao, Y., Kong, D., Yue, W., Zhang, D., Sun, X., Wang, L., et al. (2026) · Neurobiology of Stress · doi:10.1016/j.ynstr.2026.100851
Metadata
- Authors
- Hikichi, T., Akiyoshi, J., Yamamoto, Y., Tsutsumi, T., & Isogawa, K.
- Affiliations
- Oita University (JP)
- Venue
- Pharmacopsychiatry
- Publisher
- Georg Thieme Verlag KG
- Published
- 2000-09
- Volume
- 33
- Issue
- 5
- Pages
- 189-193
- ISSN
- 0176-3679 (ISSN-L)
- 1439-0795
- OpenAlex
- W2016605777
- Cited by
- 47
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2020: 1 · 2017: 1 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 1.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pharmacopsychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
- Keywords
- corticotropin-releasing factor, CRF receptor antagonists, CP-154,526, fear conditioning, anxiety, footshock, freezing behavior, fear acquisition, fear expression, rats
- MeSH terms
- Animals, Conditioning, Psychological, Electroshock, Fear, Male, Motor Activity, Pyrimidines, Pyrroles, Rats, Wistar, Receptors, Corticotropin-Releasing Hormone, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.